Lista de obras - Mauro Giuseppe Mastropasqua

A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer.

artículo científico publicado en 2010

A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer

artículo científico publicado en 2012

Accelerated partial breast irradiation with intraoperative electrons: using GEC-ESTRO recommendations as guidance for patient selection

artículo científico publicado en 2012

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

artículo científico publicado en 2007

An international study to increase concordance in Ki67 scoring

artículo científico publicado en 2015

Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.

artículo científico publicado en 2015

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial

scientific article published on 11 March 2013

BETA-GALACTOSYLCERAMIDASE PROMOTES MELANOMA GROWTH VIA MODULATION OF CERAMIDE METABOLISM

artículo científico publicado en 2020

Breast cancer subtypes and outcome after local and regional relapse ⬇️

artículo científico publicado el 27 de abril de 2011

Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy.

artículo científico publicado en 2014

Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.

artículo científico publicado en 2008

Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

artículo científico publicado en 2010

Clinical and pathological assessment of high-risk ductal and lobular breast lesions: What surgeons must know

artículo científico publicado en 2016

Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study

scientific article published on 28 August 2020

Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution.

artículo científico publicado en 2004

Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast.

artículo científico publicado en 2014

Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons

artículo científico publicado en 2017

DCIS and LCIS are confusing and outdated terms. They should be abandoned in favor of ductal intraepithelial neoplasia (DIN) and lobular intraepithelial neoplasia (LIN).

artículo científico publicado en 2013

Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies.

artículo científico publicado en 2003

Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer.

artículo científico publicado en 2015

HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH?

scientific article published on 12 March 2012

Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome.

artículo científico publicado en 2012

High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy.

artículo científico publicado en 2013

How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists ⬇️

artículo científico publicado el 25 de mayo de 2012

How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology

artículo científico publicado en 2012

Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.

artículo científico publicado en 2011

Male breast cancer

scientific article published on 01 June 2010

Outcome and Medial Presentation of Breast Cancer: European Institute of Oncology Experience.

artículo científico publicado en 2015

Paget's disease as a local recurrence after nipple-sparing mastectomy: clinical presentation, treatment, outcome, and risk factor analysis.

artículo científico publicado en 2012

Positive axillary sentinel lymph node: is axillary dissection always necessary?

artículo científico

Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

artículo científico publicado en 2008

Primary Breast Extranodal Marginal Zone Lymphoma in Primary Sjögren Syndrome: Case Presentation and Relevant Literature

scientific article published on 10 December 2020

Primary and secondary angiosarcomas of the breast: a single institution experience ⬇️

artículo científico publicado el 30 de diciembre de 2011

Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse.

artículo científico publicado en 2012

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.

artículo científico publicado en 2010

Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes

artículo científico publicado en 2011

Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.

artículo científico publicado en 2009

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole

artículo científico publicado en 2008

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

artículo científico publicado en 2007

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

artículo científico publicado en 2014

Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.

artículo científico publicado en 2006

Risk of Locoregional Recurrence in Patients With False-Negative Frozen Section or Close Margins of Retroareolar Specimen in Nipple-Sparing Mastectomy

artículo científico publicado en 2012

Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report

artículo científico publicado en 2006

Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression

artículo científico publicado en 2013

What can the pathologist offer for optimal treatment choice?

artículo científico publicado en 2010

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial.

artículo científico publicado en 2011

[The stereotaxic core breast biopsy using the Mammotome: an alternative to intraoperative examination]

artículo científico publicado en 2002

β3 adrenergic receptor as potential therapeutic target in ADPKD

artículo científico publicado en 2021

Lista de obras de Mauro Giuseppe Mastropasqua

A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer.

A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer

Accelerated partial breast irradiation with intraoperative electrons: using GEC-ESTRO recommendations as guidance for patient selection

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

An international study to increase concordance in Ki67 scoring

Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial

BETA-GALACTOSYLCERAMIDASE PROMOTES MELANOMA GROWTH VIA MODULATION OF CERAMIDE METABOLISM

Breast cancer subtypes and outcome after local and regional relapse ⬇️

Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy.

Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.

Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

Clinical and pathological assessment of high-risk ductal and lobular breast lesions: What surgeons must know

Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study

Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution.

Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast.

Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons

DCIS and LCIS are confusing and outdated terms. They should be abandoned in favor of ductal intraepithelial neoplasia (DIN) and lobular intraepithelial neoplasia (LIN).

Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies.

Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer.

HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH?

Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome.

High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy.

How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists ⬇️

How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology

Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.

Male breast cancer

Outcome and Medial Presentation of Breast Cancer: European Institute of Oncology Experience.

Paget's disease as a local recurrence after nipple-sparing mastectomy: clinical presentation, treatment, outcome, and risk factor analysis.

Positive axillary sentinel lymph node: is axillary dissection always necessary?

Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

Primary Breast Extranodal Marginal Zone Lymphoma in Primary Sjögren Syndrome: Case Presentation and Relevant Literature

Primary and secondary angiosarcomas of the breast: a single institution experience ⬇️

Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse.

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.

Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes

Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.

Risk of Locoregional Recurrence in Patients With False-Negative Frozen Section or Close Margins of Retroareolar Specimen in Nipple-Sparing Mastectomy

Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report

Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression

What can the pathologist offer for optimal treatment choice?

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial.

[The stereotaxic core breast biopsy using the Mammotome: an alternative to intraoperative examination]

β3 adrenergic receptor as potential therapeutic target in ADPKD